Stay updated on Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Sign up to get notified when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page

  1. Check
    4 days ago
    Change Detected
    Summary
    The CONCERT study record for the Phase 2 AXS-12 (reboxetine) trial is displayed, including its design, eligibility criteria, locations, and outcome measures. It also includes study documents and record dates.
    Difference
    50%
    Check dated 2026-11-08T01:11:51.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The 403 Forbidden message and Home link are gone, and the site revision changes from v3.7.2 to v3.8.0. The study-record content area appears otherwise empty.
    Difference
    0.6%
    Check dated 2026-10-31T19:30:54.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide banner announces updates and FAQs about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the study page, which displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-24T20:30:40.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-17T21:56:46.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site revision label in the page footer changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T21:56:58.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study content and preventing access to the CONCERT trial details on this page.
    Difference
    17%
    Check dated 2026-09-19T18:50:42.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.